LINDSEY PATERSON: Open Payments
NPI 1356911069 · LAWTON, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$736 in 32 payments from 15 companies in 2025. Trend: 2023 $395 · 2024 $541 · 2025 $736
Food & beverage: $736
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 5 | $115 |
| Neurocrine BioSciences, Inc. | 4 | $99 |
| SK Life Science, Inc. | 4 | $89 |
| EMD Serono, Inc. | 3 | $83 |
| Lundbeck LLC | 4 | $76 |
| Merz Pharmaceuticals, LLC | 1 | $43 |
| PFIZER INC. | 2 | $35 |
| Lilly USA, LLC | 2 | $35 |
| ARGENX US, INC. | 1 | $28 |
| ABBVIE INC. | 1 | $26 |
Products named: INGREZZA, VYEPTI, Fintepla, Xeomin, NURTEC ODT, KISUNLA, Nayzilam, Rystiggo.
Industry payments across OK — which companies pay providers there.
